Doctor-patient-family collaboration in community-based chronic disease management to enhance multidimensional value.

Patient Educ Couns

Guangdong Medical University, Institute of Public Health and Wellness, No.1 Xincheng Avenue, Songshanhu District, Dongguan, Guangdong 523808, China; Guangdong Medical University, The Affiliated Dongguan Songshan Lake Central Hospital, No.1 Xianglong Road, Shilong Town, Dongguan, Guangdong 523808, China. Electronic address:

Published: December 2024

The United Nations Sustainable Development Goal (SDG 3) aims to strengthen healthcare systems, combat chronic and infectious diseases, and improve global health. However, chronic diseases pose significant public health challenges, straining healthcare resources and escalating economic burdens. In China, they affect 180 million people, account for over 90 % of the national disease burden, and are the leading cause of mortality. Community chronic disease management faces challenges such as limited capacity, uneven resource allocation, and weak information systems. Despite policies to improve primary healthcare, outcomes remain modest due to implementation gaps. Addressing these issues requires creating "multidimensional value" through collaboration among doctors, patients, families, and communities. This framework emphasizes functional value (efficiency), social value (community ties), emotional value (well-being), and health value (better outcomes). However, most research narrowly focuses on doctor-patient collaboration, overlooking broader dynamics involving families and community healthcare providers. By explicitly exploring the goals and collaborative roles of doctor-patient-family value co-creation in community chronic disease management, we aim to develop well informed strategies to enhance interaction and resource integration, offering insights for China and scalable solutions for global health.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.pec.2024.108604DOI Listing

Publication Analysis

Top Keywords

chronic disease
12
disease management
12
global health
8
community chronic
8
chronic
5
doctor-patient-family collaboration
4
collaboration community-based
4
community-based chronic
4
disease
4
management enhance
4

Similar Publications

Patients in need of a kidney transplant have the option of receiving a kidney from a living donor or a deceased donor. Patients in the United States who do not have an available living donor typically wait on the deceased donor waiting list for an average of three to five years, although some patients may wait longer. The waiting list is very complex and intended to allocate kidneys in a fair and equitable manner.

View Article and Find Full Text PDF

The Kidney Health Score: A Practical Guide to Early Detection of Kidney Disease Risk for Optimal Kidney Health.

Nephrol Nurs J

January 2025

Professor of Medicine, Department of Internal Medicine, Division of Nephrology, School of Medicine, Virginia Commonwealth University.

Chronic kidney disease (CKD) affects 10% of the global population, with increasing prevalence driven by diabetes, hypertension, and aging populations. CKD often progresses asymptomatically, frequently undetected until advanced stages, and may require costly treatments, such as dialysis or transplantation. CKD imposes a substantial financial burden on health care systems, with management costs rising sharply as the disease progresses, underscoring the need for early, cost-effective interventions.

View Article and Find Full Text PDF

Background: Acne is an inflammatory skin disease afflicting the majority of the world's population at some point in their lifetime, and is seen to be chronic in about 50% of cases. Acne leads to significant social withdrawal, depression, and disfiguring scars in many cases. Available treatments are characterized by high rates of relapse, dangerous side effects, and social stigma, which often leads to poor patient compliance and treatment failure.

View Article and Find Full Text PDF

Multiple sclerosis and infection: history, EBV, and the search for mechanism.

Microbiol Mol Biol Rev

January 2025

Department of Molecular Genetics & Microbiology, Center for Virology, Duke University, Durham, North Carolina, USA.

SUMMARYInfection has long been hypothesized as the cause of multiple sclerosis (MS), and recent evidence for Epstein-Barr virus (EBV) as the trigger of MS is clear and compelling. This clarity contrasts with yet uncertain viral mechanisms and their relation to MS neuroinflammation and demyelination. As long as this disparity persists, it will invigorate virologists, molecular biologists, immunologists, and clinicians to ascertain how EBV potentiates MS onset, and possibly the disease's chronic activity and progression.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!